Clinical Trial Update: Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update describes ongoing assessment of the potential for chronic liver injury in participants treated with Epidiolex (cannabidiol) o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dravet Syndrome
• Lennox-gastaut Syndrome
• Tuberous Sclerosis Complex

Drugs mentioned

• EPIDIOLEX (Cannabidiol)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Lennox Gastaut Syndrome, Dravet Syndrome | Phase 4 | Status: ACTIVE_NOT_RECRUITING